ABOUT THE CONFERENCE

In an effort to curb costs and expedite time to market, the pharmaceutical industry is increasingly turning to Manufacturing Execution Systems (MES) to optimize manufacturing quality via an integrated system monitoring the overall production process. Among the numerous benefits to MES implementation, the shift towards a paperless system enables a single source of manufacturing data as well as timely insight into all manufacturing stages, allowing for prompt corrective action in the event of quality concerns. In addition, MES also ensures the correct information is being collected throughout the manufacturing continuum, critical to remaining compliant with data archiving and integrity regulatory requirements.

The 3rd Annual Pharmaceutical Manufacturing Execution Systems Conference will address timely concerns facing those within manufacturing IT and automation through in-depth case studies, interactive panels and small group discussions. Topics to be explored will include movement towards cloud-based data storage, release by exception, and establishing system support coupled with end user perspectives on technology ease of use. During the conference, attendees, speakers and vendors will have the opportunity to share best practices and discuss the future of the industry to drive the safe and efficient production of pharmaceutical products.

Topics to be Addressed Include:

• Building a robust support system for MES implementation
• Developing a business case to secure MES corporate buy-in
• Expedition of MES software validation for a smooth system adoption
• Movement from existing MES technology to next generation systems
• Forecasting challenges and benefits in industry MES standardization
• Developing an exhaustive selection criteria for optimized MES selection
• Looking to the future: Showcase of new and optimized vendor technologies
• Movement from standard data centers to cloud-based data storage systems
• Standardization of MES technologies and platforms across manufacturing sites
• Direct impact of medical advancements including personalized medicine on MES
• Electronic batch records: Creating a baseline of mandatory vs. non-essential data
• System-wide integration of ERP and MES: Opportunities and challenges to overcome
• Effective MES end-user training to ensure manufacturing continuum post-integration
• Industry perspective on building a Manufacturing Execution System from the ground-up
• Proactive approach to system enhancements and updates throughout the MES lifecycle
• FDA Data Integrity Guidance: Specific impact on MES data collection and archiving structure
• Review of integration challenges for MES and the Industrial Internet of Things in manufacturing
• Opportunities in minimizing product line recipes within MES and advance towards standardization

ABOUT THE CONFERENCE

The 3rd Annual Pharmaceutical Manufacturing Execution Systems Conference will address timely concerns facing those within manufacturing IT and automation through in-depth case studies, interactive panels and small group discussions. Topics to be explored will include movement towards cloud-based data storage, release by exception, and establishing system support coupled with end user perspectives on technology ease of use. During the conference, attendees, speakers and vendors will have the opportunity to share best practices and discuss the future of the industry to drive the safe and efficient production of pharmaceutical products.